17606177

Source:http://linkedlifedata.com/resource/pubmed/id/17606177

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027121, umls-concept:C0032659, umls-concept:C0035647, umls-concept:C0086583, umls-concept:C0205217, umls-concept:C0332281, umls-concept:C0360714
pubmed:issue	8
pubmed:dateCreated	2007-7-3
pubmed:abstractText	We quantified the risk of myositis associated with statin and fibrate drug use with other covariates within a managed care organization (MCO) population.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8801383
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Clofibric Acid, http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0895-4356
pubmed:author	pubmed-author:EssawiG HGH, pubmed-author:GlanzMortonM, pubmed-author:HokansonJohn EJE, pubmed-author:McClureDavid LDL, pubmed-author:ValuckRobert JRJ
pubmed:issnType	Print
pubmed:volume	60
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	812-8
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:17606177-Age Factors, pubmed-meshheading:17606177-Aged, pubmed-meshheading:17606177-Clofibric Acid, pubmed-meshheading:17606177-Cohort Studies, pubmed-meshheading:17606177-Confidence Intervals, pubmed-meshheading:17606177-Confounding Factors (Epidemiology), pubmed-meshheading:17606177-Creatine Kinase, pubmed-meshheading:17606177-Drug Administration Schedule, pubmed-meshheading:17606177-Drug Therapy, Combination, pubmed-meshheading:17606177-Female, pubmed-meshheading:17606177-Humans, pubmed-meshheading:17606177-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:17606177-Hyperlipidemias, pubmed-meshheading:17606177-Hypolipidemic Agents, pubmed-meshheading:17606177-Kidney Diseases, pubmed-meshheading:17606177-Liver Diseases, pubmed-meshheading:17606177-Male, pubmed-meshheading:17606177-Managed Care Programs, pubmed-meshheading:17606177-Middle Aged, pubmed-meshheading:17606177-Myositis, pubmed-meshheading:17606177-Odds Ratio, pubmed-meshheading:17606177-Proportional Hazards Models, pubmed-meshheading:17606177-Risk, pubmed-meshheading:17606177-Risk Assessment, pubmed-meshheading:17606177-Sex Factors, pubmed-meshheading:17606177-Time Factors
pubmed:year	2007
pubmed:articleTitle	Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.
pubmed:affiliation	Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80237-8066, USA. david.1.mcclure@kp.org
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't